HCV Current Initiative
HCV Current is a national initiative of the ATTC Network to increase hepatitis C (HCV) knowledge among medical and behavioral health professionals.
HCV RNA Provider Card (PDF)
This ATTC initiative disseminates the latest on the rapidly evolving field of HCV and provides comprehensive resources for health professionals, including:
- Online and In-Person Curriculum and Training
- Provider Tools Available for Download
- A Guide to Assist Opioid Treatment Programs in Integrating HCV Testing and Treatment
HCV Current is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Why Hepatitis C?
An estimated 2.4 million Americans are living with hepatitis C (HCV). Many people who have HCV do not know they have it. Certain factors, such as injection drug use, can increase a person’s risk for HCV. In March 2020, the U.S. Preventive Services Task Force published a final recommendation statement recommending that clinicians screen all adults aged 18-79 years for HCV.
HCV rates increased 71% from 2014-2018. Two-thirds of new cases occurred in people 20-39 years old, the age group most impacted by the opioid epidemic. Unsafe injection drug use is cited as a major contributor to this increase in HCV infections. (National Viral Hepatitis Plan 2021-2025).
HCV Snapshot: An Introduction to Hepatitis C for Health Care Professionals | HealtheKnowledge Course (Updated in 2019)
- Free, 90-minute online course providing an overview of HCV. The four self-paced modules cover: populations at risk, overview of HCV, screening processes, and treatment options. Continuing education is available.
- learn more about the course, or
- Register now for the course at HealtheKnowledge.org
This 6-hour face-to-face training curriculum was recently updated in 2019 and includes the latest in treatment options available and the impact of the opioid epidemic on HCV in the U.S. The course is designed to instruct behavioral health and medical providers on hepatitis C (HCV) epidemiology, opportunities for promoting HCV screening and testing, treatment options and considerations, and linking persons infected to HCV health care.
By the end of this training, participants should be able to:
- List at least three populations impacted by the opioid crisis, 2019.
- List at least three infections that result from injection drug use.
- Discuss at least two reasons why it is important to promote hepatitis C screening and confirmatory diagnostic testing.
- Describe at least three prevention messages that can be used when promoting hepatitis C screening and testing.
- List at least three treatment factors to consider and describe at least two new treatment options available for patients with HCV.
- Provide examples of at least three strategies to link persons infected with HCV to HCV-focused health care.
Request a Hepatitis C training by contacting the ATTC in your region.
National HCV Products and Resources
Last Updated July 29, 2020